Holder of the Canada Research Chair in Law and Medicine, she served on the Royal Commission on Reproductive Technologies and was awarded the 2021 Canadian Bioethics Society Lifetime Achievement Award. Her research at the intersection of law, medicine and policy spans a broad portfolio of health issues, such as tissue engineering, precision oncology, biomarkers, artificial intelligence, the use of medical data and treatment with stem cells. She was a member of the International Commission on the Clinical Use of Human Germline Genome Editing (2020).  Prof. Knoppers has participated in the work of UNESCO (1987) and the OECD (2017).   She has received numerous awards and honours, and has chaired and continues to chair numerous ethics committees and international panels such as the Regulatory and Ethics Workstream of the Global Alliance for Genomics and Health.
Further information: ↗ https://www.genomicsandpolicy.org/en/team-member/no9 

Abstract

International Legal Comparative Perspectives on Human Embryo Research

Human embryo research is governed differently under diverse legal systems largely due to distinct historical, social, and political influences. Such differences in the law governing human embryo research impacts its permissibility as well as accompanying sanctions. This presentation analyses the diversity of legislative approaches and governance structures at the international, regional, and national levels. Is there a model law or approach that ensures respect for the human embryo while still protecting the human rights of citizens? Laws governing the use of embryos in science may rely on the stage of development of the embryo or simply impose a time limit or a general prohibition with no regard to development or scientific understanding. Other mechanisms such as funding restrictions or criminal sanctions may also be used. How can the future governance of human embryo research in Germany be informed through International “lessons learned”?